Point72 Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3M | Buy |
2,951,132
+2,336,817
| +380% | +$26.3M | 0.07% | 301 |
|
|
2025
Q1 | $6.2M | Buy |
+614,315
| New | +$6.2M | 0.01% | 616 |
|
|
2024
Q3 | – | Sell |
-647,126
| Closed | -$6.84M | – | 1628 |
|
|
2024
Q2 | $6.84M | Buy |
647,126
+185,226
| +40% | +$1.96M | 0.02% | 580 |
|
|
2024
Q1 | $4.87M | Buy |
461,900
+28,200
| +7% | +$297K | 0.01% | 728 |
|
|
2023
Q4 | $4.87M | Sell |
433,700
-2,272,700
| -84% | -$25.5M | 0.01% | 734 |
|
|
2023
Q3 | $31.6M | Buy |
+2,706,400
| New | +$31.6M | 0.09% | 262 |
|
|
2023
Q1 | – | Sell |
-576,800
| Closed | -$4.61M | – | 1949 |
|
|
2022
Q4 | $4.61M | Buy |
+576,800
| New | +$4.61M | 0.02% | 653 |
|
|
2022
Q3 | – | Sell |
-876,996
| Closed | -$3.57M | – | 1321 |
|
|
2022
Q2 | $3.57M | Buy |
+876,996
| New | +$3.57M | 0.02% | 665 |
|